ISSN: 2474-9214
Authors: Muratova DK , Ergashev NA and Asrarov MI
Recently, the properties of mitochondrial ATP-dependent potassium (mitoK+ATP-channel) channels isolated from various organs have been deeply studied. Activation of the MitoK+ATP-channel leads to an increase in the size of mitochondria, acceleration of ATP synthesis, stimulation of respiration. In order to find new, effective modulators of mitoK+ATP-channel, the effect of diterpenoid alkaloids thalatisamine and its derivative 14-O-benzoyltalatisamine isolated from Aconitum talassicum plant on mitoK+ATP-channel in rat liver and heart was studied. According to the results of the study, concentrations of 30 and 50 μM of talatisamine, compared to the control, decreased the mitoK+ATP-channel of the liver by 72.1±2.1% and 107.7±2.0%, respectively, and the mitoK+ATP-channel of the heart by 37.1 ±2.4% and 88.5±2.9% reliable activation was found. Under these conditions, concentrations of 30 and 50 μM of 14-O-benzoyltalatisamine decreased liver mitoK+ATP-channel by 145±2.3% and 196±2.5%, respectively, and heart mitoK+ATP-channel by 116±3, 1% and activated by 149.7±2.5% reliable activation. According to the obtained results, the effect of 14-O-benzoyltalatisamine on liver and heart mitoK+ATP-channel was found to be more active compared to talatizamine alkaloid. Therefore, this alkaloid and its derivative require a wide range of studies as a cytoprotector and cardioprotective agent protecting against ischemia by activating the mitoK+ATP-channel of the liver and heart.
Keywords: Talatisamine; 14-О-Benzoyltalatisamine; Mitochondrial ATP-Dependent Potassium Channel; Liver; Heart
Chat with us on WhatsApp